Capricor Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Capricor Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Capricor Therapeutics Inc
Rating: 1.05341675
Author: Trendlyne DVM scores

about

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in mu...

6.48 0.13 (2.05%)

72.31% Fall from 52W High

619.4K

XNAS Volume

XNAS 09 Sep, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

12.7 / 100

Technically Bearish

29.5 / 100

1Yr Price target upside is 218%

10 analysts

Capricor Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Capricor Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in mu...

72.31% Fall from 52W High

SWOT Analysis

Capricor Therapeutics Inc Live Price Chart